Umbra Applied Technologies Launches Redesigned Website

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
33
Umbra Applied Technologies Launches Redesigned Website

TAMPA, FL--(Marketwired - Jul 26, 2017) - Umbra Applied Technologies Group ( OTC : UATG ) announced today that its subsidiary Umbra Applied Technologies (UAT) has launched its newly updated website www.umbraappliedtechnologies.com .

As a leader in advanced technologies the new website provides quick and intuitive access to its versatile product lines, as well as extensive resources for customers and investors looking to keep abreast of the most advanced industry specific technologies available.

Taking three and a half months to complete, the company's new web portal has been redesigned to focus primarily on customers' interests and needs while accomplishing the underlying goal of becoming the most trusted name in the defense technology industry. To help execute this project, UAT's IT department partnered with Boost Local, a Las Vegas based digital marketing and design agency. Boost Local, a Premier Google Partner, started with an extensive strategy phase which included click through analysis, search optimization analytics and interviewing past and current customers to determine what data they were most interested in and how to deliver that content to them. Next, they executed a creative production effort to leverage these findings and implement best practice techniques including website design and search engine optimization (SEO). The newly launched website provides a more enhanced and effective user experience for customers while showcasing the range of products and service offerings of the company.

As a result of the enhanced user flow, pages per session increased by 53%, average time on site increased 33% and bounce rate has decreased to an industry leading 7%.

The new website features include enhanced search engine optimization (SEO) techniques that ensure UAT content is made more broadly available. Page speed is improved by more than 53%. The company's stated goal is to reach a wider range of users across all device types with a fully responsive website design that allows the company to present the ultimate user experience across multiple devices. This allows UAT to reach a wider range of users via search advertising as well as social media marketing. The new user interface (UI) represents the cornerstone of the Umbra applied technologies digital presence. This model will be rolled out across all of the company's division, product suites and services within the Umbra family in the coming months and is in preparation of its ecommerce launch.

Alex Umbra, UAT's Chief Executive Officer, stated, "We see dramatic benefits to this relationship with Boost Local as we launch several retail products during Q3 and Q4 of this year. The new website has been completely redesigned to offer the ultimate user-friendly experience with improved navigation and functionality while allowing customers to see our full product portfolio."

Simplified design elements to reflect a minimalist approach are apparent throughout the user's web experience and in keeping with the marketing of a powerful brand like UAT. Simplified site navigation designed with a more intuitive feel enhances a user's search capability making it simpler to find the appropriate product or application information to suit a wide range of solutions.

The new UAT website features convenient portals to request information, hyperlinks to subsidiaries, historical and current stock price charts, UAT news, events, latest product innovations and an employment portal accessing job opportunities.

When asked about the design differences between the old and new website design, why it was important to redesign the site and how the new site represented UAT, Mr. Umbra responded, "We are first and foremost a technology company and as technology must evolve we must evolve as well. Uncompromising in its precise design and performance, it is more accurate, more efficient and more dynamic. A clearer representation of who we are as a company and what our capabilities are among the market segments we operate. We are introducing a new way to interact with our company's online presence in a way that is more inclusive of all who have an interest in UAT."

Visitors to the new site can stay informed with the latest UAT and industry news by signing up for the UAT newsletter or clicking on the company's social media links. The newsletter will contain richer online content such as press releases, featured products, shareholder information and company news.

Additionally, UAT has been working tirelessly behind the scenes developing multiple new products and verticals that are expected to launch in the near future. The company believes the new product pipelines under development will bring significant value to all UAT shareholders.

For more information on UAT, A subsidiary of UAT Group, Inc. and to view the site, please visit www.umbraappliedtechnologies.com .

About Umbra Applied Technologies Group, Inc.

Umbra Applied Technologies is a member of the Umbra Applied Technologies Group ( OTC : UATG ) family of companies. Umbra Applied Technologies, U.S. based Defense and Security Company, is engaged in the research, design, development, manufacture, integration, and sustainment of advanced technology systems, products, and services for defense, civil, and commercial applications in United States and internationally. It also provides management, engineering, technical, scientific, logistic, and information services.

In support of air, land and naval forces, the company operates in five segments: Aeronautics, Information Systems & Global Solutions, Biotech, Alternative & Renewable Energy, and Intelligence Systems. The Aeronautics segment offers military aircrafts, such as unmanned combat and air mobility aircrafts, and related technologies. The Information Systems & Global Solutions segment provides advanced technology systems and security expertise, integrated information technology solutions, and management services for civil, defense, intelligence, and other government customers. The Biotech segment addresses critical gaps that are absent in defense medical research programs. The Alternative & Renewable Energy segment provides alternative solutions to energy through research in bio-electricity, wind, thermodynamic and solar energy. The Intelligence segment provides computational study of signals, open source and network intelligence through advanced metrics and algorithms to locate and extract sentiment from gathered intelligence.

For more information visit www.uatgroup.com or www.umbraappliedtechnologies.com

Forward-Looking and Cautionary Statements

This press release contains "forward-looking" statements that are based on present circumstances and on Umbra Applied Technologies Group predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements, including any statements regarding the plans and objectives of management for future operations or products, the market acceptance or future success of our products, and our future financial performance, are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements.

Forward-looking statements are made only as of the date of this release and Umbra Applied Technologies does not undertake and specifically declines any obligation to update any forward-looking statements. Readers should not place undue reliance on these forward-looking statements.

Investor and Media Contact: Everest Corporate Advisors, Inc. (702) 902-2361 (702) 982-1339

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Class Action Greenlighted Against Concordia for Title IX Violations

Updated Category News Views 87

Paving the Way for Equality in Campus Sports Ah, courts and colleges—two institutions you'd hope would play by the rules. But here we are, knee-deep in a legal battle with Concordia University Irvine (CUI) caught in the crosshairs of Title IX compliance issues. No surprise there when a federal court finally gave the nod for a class action to plow ahead. Class Action...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 104

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Microsoft's Cloud Misstep: Recovery Plans in Focus

Updated Category News Views 149

Microsoft's Stumble Puts CIOs on Alert Thursday's Microsoft 365 outage, a wrench in the works for every firm that ties its daily operations to these cloud services, has brought some harsh truths to the table. On November 12, outages hit users hard, preventing access to Exchange Online mailboxes and sending ripples through Teams, SharePoint, Copilot, and Defender. You...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 118

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 202

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 162

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 179

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Maritime Safety Urged After New Orleans Vessel Incident

Updated Category News Views 109

The Mississippi River saw a bit of drama near the Port of New Orleans when a river cruise turned into an unexpected rescue operation. Listen up, because incidents like this bring maritime safety right to the forefront; we can't ignore the waters that shape our daily lives here in the Big Easy. Navigating the Waters Safely Some 150 souls found themselves in a pickle when...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 134

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Updated Category News Views 145

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...

Continue Reading

Top 5 Most Recently Viewed Articles

Kimbell Royalty Partners Engages Investors at Key Conferences

Updated Category News Views 101

Kimbell Royalty Partners to Attend Notable Investor Conferences Kimbell Royalty Partners, LP (NYSE: KRP) is a prominent owner of oil and natural gas mineral and royalty interests. The company proudly manages over 129,000 gross wells across multiple states. In an effort to strengthen investor relations and share its strategic outlook, Kimbell has announced its...

Continue Reading
Karsan's Autonomous Bus Debuts at Efteling Park

Updated Category News Views 72

A Leap Towards Autonomous Mobility What we have here is Karsan breaking new ground again. They've rolled out their Autonomous e-ATAK at Efteling, the famous theme park in the Netherlands. And that's not just any park—it's a place teeming with tourists, a hotspot demanding efficient transport. Yet, these folks aren't just cranking out fancy gadgets for showing off....

Continue Reading
EyePoint Pharmaceuticals Expands Workforce with Stock Options

Updated Category News Views 301

EyePoint Pharmaceuticals Expands Workforce with Stock Options EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a dynamic biopharmaceutical company, is on a mission to enhance the lives of patients facing serious retinal diseases. Recently, the company made a notable announcement regarding the expansion of its team through the granting of non-statutory stock options to new...

Continue Reading
IonQ Shares: Insights Into Their Current Market Performance

Updated Category News Views 204

Overview of IonQ's Current Stock Performance IonQ Inc. IONQ shares have seen a notable decline recently, continuing a downward trend that’s persisted over the last couple of weeks. As the company gears up to announce its second-quarter earnings, investors are closely monitoring the developments, particularly the anticipated shift in stock momentum. Market Sentiment and...

Continue Reading
Exploring the Promising CD47 Inhibitor Drug Market Growth

Updated Category News Views 40

Understanding the CD47 Inhibitor Drug Market Gaining insights into the CD47 inhibitor drug market is crucial for recognizing the changes and advancements in cancer immunotherapy. These drugs play a vital role in the battle against cancer by harnessing the body's immune system to identify and eliminate malignant cells. CD47's Role in Cancer CD47, often referred to as the...

Continue Reading